These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35050752)

  • 1. Palbociclib in Patients With Non-Small-Cell Lung Cancer With
    Ahn ER; Mangat PK; Garrett-Mayer E; Halabi S; Dib EG; Haggstrom DE; Alguire KB; Calfa CJ; Cannon TL; Crilley PA; Gaba AG; Marr AS; Sangal A; Thota R; Antonelli KR; Islam S; Rygiel AL; Bruinooge SS; Schilsky RL
    JCO Precis Oncol; 2020 Nov; 4():757-766. PubMed ID: 35050752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palbociclib in Patients With Soft Tissue Sarcoma With
    Schuetze S; Rothe M; Mangat PK; Garrett-Mayer E; Meric-Bernstam F; Calfa CJ; Farrington LC; Livingston MB; Wentzel K; Behl D; Kier Y; Marr AS; von Mehren M; Press JZ; Thota R; Grantham GN; Gregory A; Hinshaw DC; Halabi S; Schilsky RL
    JCO Precis Oncol; 2024 Jul; 8():e2400219. PubMed ID: 39013131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palbociclib in Patients With Head and Neck Cancer and Other Tumors With
    Worden FP; Pisick E; Rothe M; Mangat PK; Garrett-Mayer E; Khalil MF; Carrizosa DR; Bauman JR; Leidner RS; Duvivier HL; Fu S; Park MS; Yost KJ; Calfa CJ; Marr AS; Balmanoukian AS; Behl D; Cannon TL; Nabell L; Powell SF; Thota R; Hinshaw DC; Gregory A; Grantham GN; Halabi S; Schilsky RL
    JCO Precis Oncol; 2024 Oct; 8():e2400477. PubMed ID: 39413339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palbociclib in Patients With Pancreatic and Biliary Cancer With
    Al Baghdadi T; Halabi S; Garrett-Mayer E; Mangat PK; Ahn ER; Sahai V; Alvarez RH; Kim ES; Yost KJ; Rygiel AL; Antonelli KR; Butler NL; Bruinooge SS; Schilsky RL
    JCO Precis Oncol; 2019 Dec; 3():1-8. PubMed ID: 35100714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With
    Klute KA; Rothe M; Garrett-Mayer E; Mangat PK; Nazemzadeh R; Yost KJ; Duvivier HL; Ahn ER; Cannon TL; Alese OB; Krauss JC; Thota R; Calfa CJ; Denlinger CS; O'Lone R; Halabi S; Grantham GN; Schilsky RL
    JCO Precis Oncol; 2022 Nov; 6():e2200191. PubMed ID: 36409971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With
    Ganti AK; Rothe M; Mangat PK; Garrett-Mayer E; Dib EG; Duvivier HL; Ahn ER; Behl D; Borghaei H; Balmanoukian AS; Gaba A; Li R; Osei-Boateng K; Thota R; Grantham GN; Gregory A; Halabi S; Schilsky RL
    JCO Precis Oncol; 2023 Jun; 7():e2300041. PubMed ID: 37315265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With
    Ahn ER; Rothe M; Mangat PK; Garrett-Mayer E; Ali-Ahmad HM; Chan J; Maitland ML; Patel SR; Reese Z; Balmanoukian AS; Drescher CW; Li R; Tsimberidou AM; Leath CA; O'Lone R; Grantham GN; Halabi S; Schilsky RL
    JCO Precis Oncol; 2023 Apr; 7():e2200609. PubMed ID: 37027810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With
    Cannon TL; Rothe M; Mangat PK; Garrett-Mayer E; Chiu VK; Hwang J; Vijayvergia N; Alese OB; Dib EG; Duvivier HL; Klute KA; Sahai V; Ahn ER; Bedano P; Behl D; Sinclair S; Thota R; Urba WJ; Yang ES; Grantham GN; Hinshaw DC; Gregory A; Halabi S; Schilsky RL
    J Clin Oncol; 2024 Sep; 42(27):3228-3237. PubMed ID: 38748939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Talazoparib in Patients With Solid Tumors With
    Srkalovic G; Rothe M; Mangat PK; Garrett-Mayer E; Ahn ER; Brouse G; Chan J; Mehmi I; Khalil M; Duvivier HL; Gaba A; Leuva H; Thota R; Yost KJ; Grantham GN; Gregory A; Hinshaw DC; Halabi S; Schilsky RL
    JCO Precis Oncol; 2024 Jun; 8():e2400026. PubMed ID: 38865672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib in Patients With Breast Cancer With
    Calfa CJ; Rothe M; Mangat PK; Garrett-Mayer E; Ahn ER; Burness ML; Gogineni K; Rohatgi N; Al Baghdadi T; Conlin A; Gaba A; Hamid O; Krishnamurthy J; Gavini NJ; Gold PJ; Rodon J; Rueter J; Thota R; Grantham GN; Hinshaw DC; Gregory A; Halabi S; Schilsky RL
    JCO Precis Oncol; 2024 Feb; 8():e2300513. PubMed ID: 38354330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nivolumab Plus Ipilimumab in Patients With Solid Tumors With
    Rohatgi N; Rothe M; Mangat PK; Garrett-Mayer E; Meric-Bernstam F; Pisick E; Alese OB; Reynolds CM; Thota R; Vaccaro GM; von Mehren M; Arend RC; Chiu VK; Duvivier HL; Gold PJ; Hack K; Marr AS; Winer A; Grantham GN; Hinshaw DC; Gregory A; Halabi S; Schilsky RL
    JCO Precis Oncol; 2023 Sep; 7():e2300279. PubMed ID: 38039429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
    Duvivier HL; Rothe M; Mangat PK; Garrett-Mayer E; Ahn ER; Al Baghdadi T; Alva AS; Dublis SA; Cannon TL; Calfa CJ; Li R; Behl D; Chiu VK; Gold PJ; Marr AS; Mileham KF; Powell SF; Rodon J; Thota R; Grantham GN; Gregory A; Hinshaw DC; Halabi S; Schilsky RL
    J Clin Oncol; 2023 Nov; 41(33):5140-5150. PubMed ID: 37561967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
    Alva AS; Mangat PK; Garrett-Mayer E; Halabi S; Hansra D; Calfa CJ; Khalil MF; Ahn ER; Cannon TL; Crilley P; Fisher JG; Haslem DS; Shrestha S; Antonelli KR; Butler NL; Warren SL; Rygiel AL; Ranasinghe S; Bruinooge SS; Schilsky RL
    J Clin Oncol; 2021 Aug; 39(22):2443-2451. PubMed ID: 33844595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regorafenib in Patients With Solid Tumors With
    Sahai V; Rothe M; Mangat PK; Garrett-Mayer E; Suhag V; Dib EG; Mehmi I; Kadakia KC; Pisick E; Duvivier HL; Le P; Li R; Michelin DP; Wilcox RE; Grantham GN; Hinshaw DC; Gregory A; Halabi S; Schilsky RL
    JCO Precis Oncol; 2024 Apr; 8():e2300527. PubMed ID: 38603652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With
    Gupta R; Meric-Bernstam F; Rothe M; Garrett-Mayer E; Mangat PK; D'Andre S; Ahn ER; O'Lone R; Halabi S; Grantham GN; Schilsky RL
    JCO Precis Oncol; 2022 Oct; 6():e2200306. PubMed ID: 36315917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
    Fisher JG; Tait D; Garrett-Mayer E; Halabi S; Mangat PK; Schink JC; Alvarez RH; Veljovich D; Cannon TL; Crilley PA; Pollock T; Calfa CJ; Al Baghdadi T; Thota R; Fleming N; Cotta JA; Rygiel AL; Warren SL; Schilsky RL
    Target Oncol; 2020 Dec; 15(6):733-741. PubMed ID: 33090333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
    Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
    Oncologist; 2012; 17(1):13. PubMed ID: 22210086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
    Finn RS; Crown JP; Lang I; Boer K; Bondarenko IM; Kulyk SO; Ettl J; Patel R; Pinter T; Schmidt M; Shparyk Y; Thummala AR; Voytko NL; Fowst C; Huang X; Kim ST; Randolph S; Slamon DJ
    Lancet Oncol; 2015 Jan; 16(1):25-35. PubMed ID: 25524798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
    Al Baghdadi T; Garrett-Mayer E; Halabi S; Mangat PK; Rich P; Ahn ER; Chai S; Rygiel AL; Osayameh O; Antonelli KR; Islam S; Bruinooge SS; Schilsky RL
    Target Oncol; 2020 Dec; 15(6):743-750. PubMed ID: 33068284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC).
    Raez LE; Santos ES; Webb RT; Wade J; Brito RA; Karr M; Kennah A; Childs BH
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):1103-10. PubMed ID: 24057043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.